Pathogenetic and histogenetic features of HIV-associated Hodgkin's disease

被引:52
作者
Dolcetti, R
Boiocchi, M
Gloghini, A
Carbone, A
机构
[1] Natl Canc Inst, IRCCS, Ctr Riferimento Oncol, Div Expt Oncol 1, I-33081 Aviano, PN, Italy
[2] Natl Canc Inst, IRCCS, Ctr Riferimento Oncol, Div Pathol, I-33081 Aviano, PN, Italy
关键词
Hodkin's disease; HIV; Epstein-Barr virus; CD40; LMP-1;
D O I
10.1016/S0959-8049(01)00105-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Compared with the cases in the general population, Hodgkin's disease (HD) arising in the HIV setting shows distinctive features in terms of epidemiology. aetiopathogenesis, histopathology and clinical behaviour. Although HD does not represent an AIDS-detining condition. recent evidence consistently indicates that HIV-infected individuals have a significantly increased risk of developing HD. HIV-related HD is characterised by the preponderance of aggressive histological subtypes. advanced stage at presentation, and highly malignant clinical course. Moreover, unlike HD in the general population. the large majority of HIV-related HD cases are pathogenetically linked to Epstein-Barr virus (EBV), with rates of EBV positivity ranging from 80 to 100%. Hodgkin and Reed-Sternberg cells of these cases invariably show a strong expression of the EBV-encoded latent membrane protein-1 (LMP-1), which functions as a constitutively activated tumour necrosis factor (TNF) receptor-like molecule. Usurpation of physiologically relevant pathways by LMP-1 may lead to the simultaneous or sequential activation of signalling pathways involved in the promotion of cell activation. growth, and survival, contributing thus to most of the features of HIV-related HD. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1276 / 1287
页数:12
相关论文
共 135 条
[1]  
AHMED T, 1987, CANCER, V60, P719, DOI 10.1002/1097-0142(19870815)60:4<719::AID-CNCR2820600402>3.0.CO
[2]  
2-U
[3]   HODGKINS-DISEASE AND AIDS - 23 NEW CASES AND A REVIEW OF THE LITERATURE [J].
AMES, ED ;
CONJALKA, MS ;
GOLDBERG, AF ;
HIRSCHMAN, R ;
JAIN, S ;
DISTENFELD, A ;
METROKA, CE .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1991, 5 (02) :343-356
[4]   HODGKINS-DISEASE DURING HIV-1 INFECTION - THE FRENCH REGISTRY EXPERIENCE [J].
ANDRIEU, JM ;
ROITHMANN, S ;
TOURANI, JM ;
LEVY, R ;
DESABLENS, B ;
LEMAIGNAN, C ;
GASTAUT, JA ;
BRICE, P ;
RAPHAEL, M ;
TAILLAN, B .
ANNALS OF ONCOLOGY, 1993, 4 (08) :635-641
[5]  
[Anonymous], AM J SURG PATHOL
[6]   THE CD40 ANTIGEN AND ITS LIGAND [J].
BANCHEREAU, J ;
BAZAN, F ;
BLANCHARD, D ;
BRIERE, F ;
GALIZZI, JP ;
VANKOOTEN, C ;
LIU, YJ ;
ROUSSET, F ;
SAELAND, S .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :881-922
[7]   Pathological, immunological, and molecular features of Hodgkin's disease associated with HIV infection - Comparison with ordinary Hodgkin's disease [J].
Bellas, C ;
Santon, A ;
Manzanal, A ;
Campo, E ;
Martin, C ;
Acevedo, A ;
Varona, C ;
Forteza, J ;
Morente, M ;
Montalban, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (12) :1520-1524
[8]   CANCER AMONG NEW YORK MEN AT RISK OF ACQUIRED IMMUNODEFICIENCY SYNDROME [J].
BIGGAR, RJ ;
BURNETT, W ;
MIKL, J ;
NASCA, P .
INTERNATIONAL JOURNAL OF CANCER, 1989, 43 (06) :979-985
[9]   EPSTEIN-BARR VIRUS LATENT INFECTION MEMBRANE-PROTEIN INCREASES VIMENTIN EXPRESSION IN HUMAN B-CELL LINES [J].
BIRKENBACH, M ;
LEIBOWITZ, D ;
WANG, F ;
SAMPLE, J ;
KIEFF, E .
JOURNAL OF VIROLOGY, 1989, 63 (09) :4079-4084
[10]   DEFECTIVE REGULATION OF EPSTEIN-BARR VIRUS-INFECTION IN PATIENTS WITH ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) OR AIDS-RELATED DISORDERS [J].
BIRX, DL ;
REDFIELD, RR ;
TOSATO, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (14) :874-879